603127 昭衍新药
开盘竞价 07-25 09:30:00
资讯
新帖
简况
重回3600点,牛市“旗手”涨停
中国基金报 · 07-23 04:57
重回3600点,牛市“旗手”涨停
CRO概念持续走强 昭衍新药涨停
E公司 · 07-23 02:21
CRO概念持续走强 昭衍新药涨停
异动快报:昭衍新药(603127)7月23日10点14分触及涨停板
证券之星 · 07-23 02:15
异动快报:昭衍新药(603127)7月23日10点14分触及涨停板
上半年盈利翻倍!CXO强劲反弹,昭衍新药飙升8%!A股最大医疗ETF(512170)冲高2%再刷阶段新高
新浪基金 · 07-23 02:13
上半年盈利翻倍!CXO强劲反弹,昭衍新药飙升8%!A股最大医疗ETF(512170)冲高2%再刷阶段新高
医疗服务行业盘中拉升,普蕊斯涨9.52%
市场透视 · 07-23 01:55
医疗服务行业盘中拉升,普蕊斯涨9.52%
CRO概念盘中拉升,博腾股份涨7.85%
市场透视 · 07-23 01:41
CRO概念盘中拉升,博腾股份涨7.85%
每周股票复盘:昭衍新药(603127)预计2025年上半年营收6.35亿至7.02亿
证券之星 · 07-19
每周股票复盘:昭衍新药(603127)预计2025年上半年营收6.35亿至7.02亿
医药CXO行业迎来反转?已有多家药企上半年业绩预喜
制药网 · 07-18
医药CXO行业迎来反转?已有多家药企上半年业绩预喜
昭衍新药涨5.30% 一季度订单增长刺激资金博弈
智选洞察 · 07-17
昭衍新药涨5.30% 一季度订单增长刺激资金博弈
中证1000医药卫生指数报12486.30点,前十大权重包含昭衍新药等
金融界 · 07-16
中证1000医药卫生指数报12486.30点,前十大权重包含昭衍新药等
个股概念调整|昭衍新药新增“业绩反转”概念
市场透视 · 07-15
个股概念调整|昭衍新药新增“业绩反转”概念
昭衍新药发盈喜 预期上半年归母净利约5032.43万元到7548.65万元 实现扭亏为盈
智通财经 · 07-14
昭衍新药发盈喜 预期上半年归母净利约5032.43万元到7548.65万元 实现扭亏为盈
医药生物行业:创新产业链CRO、CDMO、上游已走在不同阶段的拐点 未来可期、积极布局
中泰证券股份有... · 07-13
医药生物行业:创新产业链CRO、CDMO、上游已走在不同阶段的拐点 未来可期、积极布局
港股医药股走强 凯莱英涨超10%
E公司 · 07-11
港股医药股走强 凯莱英涨超10%
CRO指数盘中涨幅扩大至3%,美迪西涨停,昭衍新药、毕得医药、阳光诺和、益诺思跟涨。
金融界 · 07-09
CRO指数盘中涨幅扩大至3%,美迪西涨停,昭衍新药、毕得医药、阳光诺和、益诺思跟涨。
昭衍新药涨5.17%创近一年新高 政策驱动与资金共振推升股价
智选洞察 · 07-09
昭衍新药涨5.17%创近一年新高 政策驱动与资金共振推升股价
被牛市遗忘的CXO,谁将凭“拐点基因”破局
动脉网 · 07-08
被牛市遗忘的CXO,谁将凭“拐点基因”破局
国产首个丨昭衍新药助力正大天晴重组人凝血因子Ⅶa获批上市
昭衍JOINN · 07-07
国产首个丨昭衍新药助力正大天晴重组人凝血因子Ⅶa获批上市
7月7日昭衍新药创60日新高,易方达医疗保健行业混合A基金重仓该股
证券之星 · 07-07
7月7日昭衍新药创60日新高,易方达医疗保健行业混合A基金重仓该股
乐普医疗、昭衍新药等新设华夏致远创投基金
E公司 · 07-07
乐普医疗、昭衍新药等新设华夏致远创投基金
加载更多
公司概况
公司名称:
北京昭衍新药研究中心股份有限公司
所属行业:
研究和试验发展
上市日期:
2017-08-25
主营业务:
北京昭衍新药研究中心股份有限公司的主营业务是从事以药物非临床安全性评价服务为主的药物临床前研究服务和实验动物及附属产品的销售业务。公司的主要产品是药物非临床研究服务、临床服务及其他、实验模型供应。
发行价格:
12.51
{"stockData":{"symbol":"603127","market":"SH","secType":"STK","nameCN":"昭衍新药","latestPrice":28.58,"timestamp":1753406526000,"preClose":28.48,"halted":0,"volume":0,"delay":0,"changeRate":0.0035,"floatShares":630000000,"shares":749000000,"eps":0.517,"marketStatus":"开盘竞价","change":0.1,"latestTime":"07-25 09:30:00","open":0,"high":0,"low":0,"amount":0,"amplitude":0,"askPrice":28.58,"askSize":1283,"bidPrice":28.58,"bidSize":1283,"shortable":0,"etf":0,"ttmEps":0.517,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1753407000000},"marketStatusCode":1,"adr":0,"adjPreClose":28.48,"symbolType":"stock","openAndCloseTimeList":[[1753407000000,1753414200000],[1753419600000,1753426800000]],"highLimit":31.33,"lowLimit":25.63,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":749477334,"isCdr":false,"pbRate":2.63,"roa":"--","peRate":55.280464,"roe":"0.51%","epsLYR":0.1,"committee":-0.170653,"marketValue":21420000000,"turnoverRate":0,"status":0,"hkstockBrief":{"symbol":"06127","market":"HK","secType":"STK","nameCN":"昭衍新药","latestPrice":23.1,"timestamp":1753406425930,"preClose":22.8,"halted":0,"volume":10900,"delay":0,"premium":"-26.32"},"floatMarketCap":18019000000},"requestUrl":"/m/hq/s/603127","defaultTab":"news","newsList":[{"id":"2553296147","title":"重回3600点,牛市“旗手”涨停","url":"https://stock-news.laohu8.com/highlight/detail?id=2553296147","media":"中国基金报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553296147?lang=zh_cn&edition=full","pubTime":"2025-07-23 12:57","pubTimestamp":1753246656,"startTime":"0","endTime":"0","summary":"7月23日上午,A股三大指数震荡拉升,沪指站上3600点,截至午间收盘,沪指涨0.75%,深成指涨0.31%,创业板指涨0.72%。CRO板块震荡拉升CRO板块震荡拉升,昭衍新药涨停,美迪西、博腾股份、皓元医药等涨超5%。山大电力一度涨超500%7月23日,两只新股首发上市,创业板山大电力一度涨超500%。此外,技源集团今日在上交所主板上市,开盘一度涨超370%,截至发稿,N技源涨280%,总市值为166亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072313032797b1cd18&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072313032797b1cd18&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06127","BK1521","LU0314109678.HKD","02601","601665","LU2039709279.SGD","601288","688131","LU1328277881.USD","601696","603127","600864","BK1231","01288","ACGBF","LU1813983027.USD","LU0173614495.USD","LU0287142896.SGD","601601","03143","BK1560","688202"],"gpt_icon":0},{"id":"2553260061","title":"CRO概念持续走强 昭衍新药涨停","url":"https://stock-news.laohu8.com/highlight/detail?id=2553260061","media":"E公司","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553260061?lang=zh_cn&edition=full","pubTime":"2025-07-23 10:21","pubTimestamp":1753237266,"startTime":"0","endTime":"0","summary":"人民财讯7月23日电,CRO概念持续走强,截至发稿,美迪西涨超15%,昭衍新药涨停,康龙化成、博腾股份、凯莱英等跟涨。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723102106954de202&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"3a2cf9bd91f85ad98177b3a6685c0c95","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723102106954de202&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688202","06127","06821","BK0216","03759","603127"],"gpt_icon":0},{"id":"2553260752","title":"异动快报:昭衍新药(603127)7月23日10点14分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2553260752","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553260752?lang=zh_cn&edition=full","pubTime":"2025-07-23 10:15","pubTimestamp":1753236926,"startTime":"0","endTime":"0","summary":"证券之星7月23日盘中消息,10点14分昭衍新药触及涨停板。目前价格28.25,上涨10.01%。其所属行业医疗服务目前上涨。领涨股为海特生物。该股为CAR-T疗法,干细胞,基因编辑概念热股,当日CAR-T疗法概念上涨2.09%,干细胞概念上涨2.02%,基因编辑概念上涨1.68%。7月22日的资金流向数据方面,主力资金净流出6962.52万元,占总成交额11.14%,游资资金净流入548.51万元,占总成交额0.88%,散户资金净流入6414.01万元,占总成交额10.26%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025072300011715.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["06127","603127","BK1141","BK1576","BK0216"],"gpt_icon":0},{"id":"2553588298","title":"上半年盈利翻倍!CXO强劲反弹,昭衍新药飙升8%!A股最大医疗ETF(512170)冲高2%再刷阶段新高","url":"https://stock-news.laohu8.com/highlight/detail?id=2553588298","media":"新浪基金","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553588298?lang=zh_cn&edition=full","pubTime":"2025-07-23 10:13","pubTimestamp":1753236780,"startTime":"0","endTime":"0","summary":"医疗板块突围进行时!7月23日早盘,CXO概念强势反弹,昭衍新药劲涨超8%,康龙化成涨超6%,凯莱英、九洲药业、泰格医药、药明康德等均大幅跟涨。 A股最大医疗ETF盘中上探2%,盘中价再刷近4个月新高!场内交投活跃,开盘30分钟成交额突破4亿元。 消息面,日前多家CXO龙头企业中报业绩预喜。昭衍新药上半年净利最高预增144%,药明康德亦预增超100%,康龙化成最高预增11%。 还看好创新药,可以关注国内首只药ETF。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2025-07-23/doc-infhmnxu1352698.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["512170","399300","BK0216","BK1576","159828","06127","CXO","603127","BK1141","159982"],"gpt_icon":0},{"id":"2553598260","title":"医疗服务行业盘中拉升,普蕊斯涨9.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2553598260","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553598260?lang=zh_cn&edition=full","pubTime":"2025-07-23 09:55","pubTimestamp":1753235734,"startTime":"0","endTime":"0","summary":"07月23日,医疗服务行业盘中拉升,截至09点55分,医疗服务行业整体指数上涨3.03%,报6265.490点。从个股上来看,该行业的成分股中,普蕊斯涨9.52%,博腾股份、美迪西等8只股涨幅超过5%。从资金上来看,截止发稿,医疗服务行业主力净流入为5.18亿,其中昭衍新药受到资金热捧,主力净流入1.10亿;拉长时间线来看,该板块近20日主力资金净流入-37.56亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072309553497b18d2a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072309553497b18d2a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["301257","688202","BK0216","603127"],"gpt_icon":0},{"id":"2553267634","title":"CRO概念盘中拉升,博腾股份涨7.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2553267634","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553267634?lang=zh_cn&edition=full","pubTime":"2025-07-23 09:41","pubTimestamp":1753234879,"startTime":"0","endTime":"0","summary":"07月23日,CRO概念盘中拉升,截至09点41分,CRO概念整体指数上涨1.20%,报548.470点。从个股上来看,该概念的成分股中,博腾股份涨7.85%,康龙化成、凯莱英等3只股涨幅超过5%。从资金上来看,截止发稿,CRO概念主力净流入为2.89亿,其中昭衍新药受到资金热捧,主力净流入7428.00万;拉长时间线来看,该板块近20日主力资金净流入-20.67亿。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723094119954dd277&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250723094119954dd277&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03759","300363","BK0239","BK0028","BK0216","603127"],"gpt_icon":0},{"id":"2552417302","title":"每周股票复盘:昭衍新药(603127)预计2025年上半年营收6.35亿至7.02亿","url":"https://stock-news.laohu8.com/highlight/detail?id=2552417302","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552417302?lang=zh_cn&edition=full","pubTime":"2025-07-20 03:29","pubTimestamp":1752953349,"startTime":"0","endTime":"0","summary":"截至2025年7月18日收盘,昭衍新药报收于26.62元,较上周的26.02元上涨2.31%。本周,昭衍新药7月14日盘中最高价报27.04元。7月15日盘中最低价报24.46元。昭衍新药当前最新总市值199.51亿元,在医疗服务板块市值排名7/50,在两市A股市值排名829/5149。本周关注点业绩披露要点:昭衍新药预计2025年1-6月营业收入6.35亿元至7.02亿元业绩披露要点昭衍新药发布业绩预告,预计2025年1-6月营业收入6.35亿元至7.02亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025072000000766.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603127","06127"],"gpt_icon":0},{"id":"2552458949","title":"医药CXO行业迎来反转?已有多家药企上半年业绩预喜","url":"https://stock-news.laohu8.com/highlight/detail?id=2552458949","media":"制药网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552458949?lang=zh_cn&edition=full","pubTime":"2025-07-18 09:15","pubTimestamp":1752801338,"startTime":"0","endTime":"0","summary":"综合来看,多家 CXO 企业上半年业绩预喜,显示出 CXO 行业正在逐步走出低谷,迎来业绩拐点。创新药企业在获得首付后,即可与 CXO 行业企业签订合同,由此形成了 “BD 到现金流到 CXO 再到新药上市” 的正向循环。随着行业的持续回暖,CXO 企业有望在未来继续保持良好的发展态势,为全球医药创新贡献更多力量。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071809180997aa76bb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071809180997aa76bb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688076","603259","603127","159938","BK0216"],"gpt_icon":0},{"id":"2552103804","title":"昭衍新药涨5.30% 一季度订单增长刺激资金博弈","url":"https://stock-news.laohu8.com/highlight/detail?id=2552103804","media":"智选洞察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552103804?lang=zh_cn&edition=full","pubTime":"2025-07-17 13:39","pubTimestamp":1752730762,"startTime":"0","endTime":"0","summary":"昭衍新药股价今日表现强势,截至13点38分,最新价报26.64元/股,涨幅达5.30%。截至7月17日13时38分,昭衍新药A股上涨5.34%,振幅达6.32%,成交额突破6.06亿元,主力资金单日净流入3402万元,结束此前连续六日净流出态势。从消息面看,公司2025年一季度新签订单4.3亿元,同比增长7.5%,订单恢复进度快于市场预期,刺激资金短期博弈。2025年前三季度实验室服务业务净利润同比下滑96.47%,但22亿元存量订单提供安全垫。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717133928a6aef627&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717133928a6aef627&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","603127"],"gpt_icon":0},{"id":"2551143907","title":"中证1000医药卫生指数报12486.30点,前十大权重包含昭衍新药等","url":"https://stock-news.laohu8.com/highlight/detail?id=2551143907","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551143907?lang=zh_cn&edition=full","pubTime":"2025-07-16 15:48","pubTimestamp":1752652097,"startTime":"0","endTime":"0","summary":"金融界7月16日消息,上证指数低开震荡,中证1000医药卫生指数 报12486.30点。数据统计显示,中证1000医药卫生指数近一个月上涨4.34%,近三个月上涨12.39%,年至今上涨16.26%。从中证1000医药卫生指数持仓样本的行业来看,化学药占比35.86%、医疗器械占比19.60%、中药占比17.00%、生物药品占比14.32%、医疗商业与服务占比7.53%、制药与生物科技服务占比5.69%。在样本有特殊事件发生,导致其行业归属发生变更时,将对中证1000行业指数样本进行相应调整。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716155754954490f4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250716155754954490f4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688166","399852","603127","688331","159845","000001.SH","688266","000852.SH","BK0216"],"gpt_icon":0},{"id":"2551151530","title":"个股概念调整|昭衍新药新增“业绩反转”概念","url":"https://stock-news.laohu8.com/highlight/detail?id=2551151530","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551151530?lang=zh_cn&edition=full","pubTime":"2025-07-15 15:15","pubTimestamp":1752563722,"startTime":"0","endTime":"0","summary":"2025年07月15日,昭衍新药新增了业绩反转概念。昭衍新药的所属概念,还有:融资融券、创新药、生物疫苗、AH股、转融券标的、MSCI概念、专精特新、纳入富时罗素、标普道琼斯中国。个股概念调整既是市场认知的再校准,也是企业战略的显性化映射。对于投资者而言:①概念新增往往预示新业务增长点的价值重估窗口 ②概念移除需警惕业务收缩或市场预期修正风险 ③交叉验证财务数据与概念含金量是避免\"伪概念\"陷阱的关键 ④关注机构持仓变化与概念调整的协同性可捕捉主力动向。(以上内容为腾讯自选股基于公开消息,由程序或算法智能生成,仅作为用户看盘参考,不作为投资建议或交易依据。股市有风险,请谨慎决策。)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715151611a44ba6a3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250715151611a44ba6a3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603127","BK0216"],"gpt_icon":0},{"id":"2551032186","title":"昭衍新药发盈喜 预期上半年归母净利约5032.43万元到7548.65万元 实现扭亏为盈","url":"https://stock-news.laohu8.com/highlight/detail?id=2551032186","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551032186?lang=zh_cn&edition=full","pubTime":"2025-07-14 19:30","pubTimestamp":1752492629,"startTime":"0","endTime":"0","summary":"智通财经APP讯,昭衍新药(06127)公布,预计2025年1-6月份实现营业收入约人民币6.35亿-7.02亿元,同比下降约17.3%到25.2%。预计2025年1-6月份实现归属于上市公司股东的净利润约人民币5032.43万元到7548.65万元,扣除非经常性损益的净利润约人民币1883.19万元到2824.79万元,将实现扭亏为盈。公告称,业绩变动主要由于本报告期内受同业竞争影响,公司营业收入有所下降,销售订单的利润空间被压缩,毛利率同比降低,实验室服务业务净利润同比下降,发生亏损。本报告期内公司持有的生物资产市价无重大波动,生物资产自然生长带来的公允价值变动收益对业绩产生积极影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071419331195420baa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071419331195420baa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","603127"],"gpt_icon":0},{"id":"2551927013","title":"医药生物行业:创新产业链CRO、CDMO、上游已走在不同阶段的拐点 未来可期、积极布局","url":"https://stock-news.laohu8.com/highlight/detail?id=2551927013","media":"中泰证券股份有...","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551927013?lang=zh_cn&edition=full","pubTime":"2025-07-14 00:00","pubTimestamp":1752422400,"startTime":"0","endTime":"0","summary":"医药板块跟随市场,表现出结构性行情,前半周得益于国内创新药政策持续推进,国内临床前CRO 如昭衍新药、美迪西表现强劲,后半周CDMO龙头药明康德、博腾股份发布超预期中报预告,催化了创新产业链高昂的投资热情。CRO、CDMO 龙头中报业绩超预期,轻舟已过万重山,积极把握底部机会。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071410130497a50b9c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071410130497a50b9c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603127","603259","BK0216","163118","000808.SH"],"gpt_icon":0},{"id":"2550726603","title":"港股医药股走强 凯莱英涨超10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550726603","media":"E公司","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550726603?lang=zh_cn&edition=full","pubTime":"2025-07-11 09:45","pubTimestamp":1752198346,"startTime":"0","endTime":"0","summary":"人民财讯7月11日电,港股医药股走强,凯莱英涨超10%,药明康德涨超9%,昭衍新药、康龙化成、药明生物涨幅居前。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711094546a6a29f41&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":"2aef863af026efdbcf49dc72815bfda3","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250711094546a6a29f41&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1328615791.USD","LU2328871848.SGD","02269","LU1997245177.USD","LU2488822045.USD","002821","LU1997245094.SGD","159718","LU2495084118.USD","LU0456842615.SGD","603127","LU1969619763.USD","BK0132","BK0239","02359","LU1997244956.HKD","603259","BK0216"],"gpt_icon":0},{"id":"2550506101","title":"CRO指数盘中涨幅扩大至3%,美迪西涨停,昭衍新药、毕得医药、阳光诺和、益诺思跟涨。","url":"https://stock-news.laohu8.com/highlight/detail?id=2550506101","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550506101?lang=zh_cn&edition=full","pubTime":"2025-07-09 11:05","pubTimestamp":1752030351,"startTime":"0","endTime":"0","summary":"CRO指数盘中涨幅扩大至3%,美迪西涨停,昭衍新药、毕得医药、阳光诺和、益诺思跟涨。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/07/09110551578183.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["688710","688621","BK0216","BK1141","688073","603127","BK1576","688202","06127"],"gpt_icon":0},{"id":"2550506227","title":"昭衍新药涨5.17%创近一年新高 政策驱动与资金共振推升股价","url":"https://stock-news.laohu8.com/highlight/detail?id=2550506227","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550506227?lang=zh_cn&edition=full","pubTime":"2025-07-09 10:28","pubTimestamp":1752028094,"startTime":"0","endTime":"0","summary":"昭衍新药股价今日表现强势,截至10点27分,最新价为26.03元/股,上涨5.17%,创近一年新高。政策驱动与资金共振推升股价昭衍新药近期净流入受政策与资金面双重催化。国家医保局7月1日发布创新药支持政策,直接提振CXO行业预期,政策落地次日A股单日主力资金净流入1.47亿元。技术面上,股价突破22.76元关键压力位后,量能持续放大,截至7月9日10时27分,A股换手率达4.61%,创近三个月新高。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709102822a43f31b4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709102822a43f31b4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","603127"],"gpt_icon":0},{"id":"2549561112","title":"被牛市遗忘的CXO,谁将凭“拐点基因”破局","url":"https://stock-news.laohu8.com/highlight/detail?id=2549561112","media":"动脉网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549561112?lang=zh_cn&edition=full","pubTime":"2025-07-08 08:07","pubTimestamp":1751933234,"startTime":"0","endTime":"0","summary":"二级市场创新药的火热反衬出CXO的落寞。到了6月底,恒生港股通创新药指数宣布修订编制方案,剔除CXO企业,聚焦创新药核心公司。01和创新药脱钩的CXO二级市场股价走势反差的背后,是双方走到了不同的发展阶段。如今,二者明显分化的走势意味着CXO行业也走到了转型的关键节点。03业务的此消彼长业务结构性变化正在重塑CXO行业竞争格局。也就是说,临床CRO业务还将继续承压,当新开临床试验数量持续减少,内卷或更加严重。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708083555a43cb692&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250708083555a43cb692&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603127","01801","BK1576","688336","BK1141","688710","BK1583","09926","BK1161","BK1191","BK1574","03347","06127","02359","03759","06978","06821"],"gpt_icon":0},{"id":"2549283535","title":"国产首个丨昭衍新药助力正大天晴重组人凝血因子Ⅶa获批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2549283535","media":"昭衍JOINN","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549283535?lang=zh_cn&edition=full","pubTime":"2025-07-07 17:30","pubTimestamp":1751880644,"startTime":"0","endTime":"0","summary":"昭衍助力首个国产重组人凝血因子Ⅶa类生物制品获批上市!重组人凝血因子Ⅶa因其高效止血作用和独特的旁路效应,已成为抑制物阳性患者的重要治疗选择[3],并在全球范围内得到广泛应用。此前,正大天晴注射用重组人凝血因子Ⅷ(安恒吉)已获批上市。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707182753a43ba61f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707182753a43ba61f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0216","06127","603127"],"gpt_icon":0},{"id":"2549893265","title":"7月7日昭衍新药创60日新高,易方达医疗保健行业混合A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2549893265","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549893265?lang=zh_cn&edition=full","pubTime":"2025-07-07 16:22","pubTimestamp":1751876567,"startTime":"0","endTime":"0","summary":"证券之星消息,7月7日昭衍新药创60日新高,收盘报22.86元,当日涨2.24%,换手率4.95%,成交量31.22万手,成交额6.91亿元。根据2025基金Q1季报公募基金重仓股数据,重仓该股的公募基金共17家,其中持有数量最多的公募基金为易方达基金的易方达医疗保健行业混合A。易方达医疗保健行业混合A目前规模为44.75亿元,最新净值4.084,较上一交易日上涨2.92%,近一年上涨43.35%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025070700020785.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603127","06127","BK0216","BK1141","BK1576"],"gpt_icon":0},{"id":"2549309372","title":"乐普医疗、昭衍新药等新设华夏致远创投基金","url":"https://stock-news.laohu8.com/highlight/detail?id=2549309372","media":"E公司","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549309372?lang=zh_cn&edition=full","pubTime":"2025-07-07 11:35","pubTimestamp":1751859345,"startTime":"0","endTime":"0","summary":"人民财讯7月7日电,企查查APP显示,近日,华夏致远创业投资基金(北京)合伙企业(有限合伙)成立,经营范围包含:创业投资(限投资未上市企业);以私募基金从事股权投资、投资管理、资产管理等活动。企查查股权穿透显示,该企业由乐普医疗、昭衍新药等共同出资。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707113546a43aeb64&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707113546a43aeb64&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603127","BK0114","BK0196","BK0216","BK0188","BK0251","BK0042","BK0028","300003","06127","BK0201","BK0113"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1753406529630,"stockEarnings":[{"period":"1week","weight":0.0587},{"period":"1month","weight":0.4795},{"period":"3month","weight":0.8327},{"period":"6month","weight":0.8152},{"period":"1year","weight":1.1153},{"period":"ytd","weight":0.7126}],"compareEarnings":[{"period":"1week","weight":0.0253},{"period":"1month","weight":0.0541},{"period":"3month","weight":0.0943},{"period":"6month","weight":0.1086},{"period":"1year","weight":0.2425},{"period":"ytd","weight":0.0758}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"北京昭衍新药研究中心股份有限公司","boardCode":"AI0073","boardName":"研究和试验发展","stockholders":"0人","perCapita":"--","listingDate":"2017-08-25","address":"北京市大兴区北京经济技术开发区荣京东街甲5号","registeredCapital":"74947万元","survey":" 北京昭衍新药研究中心股份有限公司的主营业务是从事以药物非临床安全性评价服务为主的药物临床前研究服务和实验动物及附属产品的销售业务。公司的主要产品是药物非临床研究服务、临床服务及其他、实验模型供应。","listedPrice":12.51},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.4","shortVersion":"4.34.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"昭衍新药(603127)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供昭衍新药(603127)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"昭衍新药,603127,昭衍新药股票,昭衍新药股票老虎,昭衍新药股票老虎国际,昭衍新药行情,昭衍新药股票行情,昭衍新药股价,昭衍新药股市,昭衍新药股票价格,昭衍新药股票交易,昭衍新药股票购买,昭衍新药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"昭衍新药(603127)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供昭衍新药(603127)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}